Search

everythinglearnresearchcommunity

for

Search:↓

Osaterone acetate reduces prostate size and enzyme levels in dogs with benign prostatic hyperplasia.

Finasteride treatment lowers urine androgen and prostaglandin levels, making them potential markers for effectiveness.

Finasteride effectively reduces prostate size and symptoms in most BPH patients.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

Finasteride can reliably cause hypospadias in rabbits.

Finasteride effectively treats benign prostatic hyperplasia by reducing prostate size and improving urinary symptoms.

Finasteride may be linked to Peyronie’s disease, but more research is needed.

Dutasteride is more effective than finasteride in reducing urinary retention and surgery risks in people aged 65 and older.

Testosterone increases fluid secretion and aquaporin expression in the vas deferens, which is important for male fertility.

Post-void residual volume does not predict worsening urological symptoms in multiple sclerosis patients.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

A rare, non-cancerous ovarian tumor was successfully treated with surgery, improving the patient's symptoms.

Patients follow treatment well, but many change medicines; good information helps compliance.

Certain medications like α1-blockers, benzodiazepines, and finasteride increase the risk of floppy iris syndrome during cataract surgery.

Finasteride linked to skin inflammation.

Medications for benign prostatic syndrome can cause cognitive issues and depression.

A young man had a rare case of hair cysts on his elbows, which was hard to diagnose and treat.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

Hair loss can be an early sign of prostate enlargement.

5α-reductase inhibitors help manage symptoms of benign prostatic hyperplasia and may also prevent prostate cancer and treat hair loss.

Pregnant female urologists should avoid certain drugs and use protective measures to stay safe.

Primary care providers should understand Geschlechtsinkongruenz to offer better care for transitioning individuals.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Low-dose finasteride can cause painful breast enlargement in men, which resolves after stopping the medication.

Early hair loss may indicate future prostate issues.